Normal-weight obese syndrome: Early inflammation?

American Journal of Clinical Nutrition

Volumn 85, Issue 1, 2007, Pages 40-45

  De Lorenzo, Antonino ^a,b   Del Gobbo, Vera ^a   Premrov, Maria Grazia ^a   Bigioni, Mario ^a   Galvano, Fabio ^c   Di Renzo, Laura ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b National Istitute for Mediterranean Diet and Nutrigenomic Corso Italia   (Italy)

^c UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

Body composition; Cytokines; Fat mass; Fat free mass; Metabolic diseases

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; NORMAL WEIGHT OBESE SYNDROME; OBESITY; RISK FACTOR;

EID: 33846087022     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.1.40     Document Type: Article

References (42)

1. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 2005;64:163-9.
2. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327-32.
3. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2003;60:329-39.
4. Fortuno A, Rodriguez A, Gomez-Ambrosi J, Fruhbeck G, Diez J. Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem 2003;59:51-60.
5. Ahima RS. Central actions of adipocyte hormones. Trends Endocrinol Metab 2003;16:307-13.
6. Coppak SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001;60:349-56.
7. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005;33:1078-81.
8. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149-53.
9. Funahashi T, Nakamura T, Shimomura I, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999;38:202-6.
10. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004;30:13-9.
11. Bruun JM, Pedersen SB, Kristensen K, Richelsen B. Oppositive regulation of interleukin-8 and tumor necrosis factor-α by weight loss. Obes Res 2002;10:499-506.
12. Henrichot E, Juge-Aubry CE, Pernin A, et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 2005;29:154-65.
13. McGill HC Jr, McMahan CA, Herderick EE. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712-8.
14. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-72.
15. Frayn KN. Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 2005;6:7-13.
16. Love A, Oldford D. Metabolic syndrome. Can J Cardiovasc Nurs 2005;15:6-8.
17. Valdezeidell JC, Ahn YI, Weiss KM. A new index of abdominal adiposity as indicator of risk for cardiovascular diseases; a cross population study. Int J Obese Relat Metab Disord 1993;17:77-82.
18. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
19. De Lorenzo A, Deurenberg P, Pietrantuono M, Di Daniele N, Cervelli V, Andreoli A. How fat is obese? Acta Diabetol 2003;40(suppl):S254-7.
20. Roche HM, Phillips C, Gibney MJ. The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc 2004;64:371-7.
21. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. In: Nutrition, metabolism & cardiovascular diseases. Nutr Metab Cardiovasc Dis 2006;16:513-23 (Epub 2006 Mar 3).
22. Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V. Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int J Obes Relat Metab Disord 2002;26:48-57.
23. Grundy SMG, Brewer B, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome. Circulation 2004;109:433-8.
24. Diet, nutrition and the prevention of chronic diseases. Word Health Organ Tech Rep Ser 2003;916:1-149.
25. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics, 1998.
26. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-75.
27. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-50.
28. Ruderman N, Chisholm D, Pi-Suneir X, Schneider S. The metabolically obese normal weight revisited. Diabetes 1998;47:699-713.
29. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745-51.
30. Bruun JM, Pedersen SB, Richelsen B. Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 2001;86:1267-73.
31. Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999;147:213-25.
32. Willis C, Morris JM, Danis V, Gallery EDM. Cytokine production by peripheral blood monocytes during the normal human ovulatory menstrual cycle. Hum Reprod 2003;18:1173-8.
33. Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992;41(suppl)2:97-101.
34. Hauner H, Bender M, Haastert B, Hube F. Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord 1998;22:1239-43.
35. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005;5:70-5.
36. Vega GL. Obesity and the metabolic syndrome. Minerva Endocrinol 2000;29:47-54.
37. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004;15:2792-800.
38. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;13:96:939-49.
39. Axelsson J, Heimburger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 2005;15:131-6.
40. Tilg H, Wolf AM. Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets 2005;9:245-51.
41. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-9.
42. Chikanoa S, Sawadaa K, Shimoyamaa T, et al. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner. Gut 2000;47:779-86.